Assessment of quality of life during gonadotrophin treatment for male hypogonadotrophic hypogonadism

Clinical Endocrinology

Volumn 81, Issue 2, 2014, Pages 259-265

  Shiraishi, Koji ^a   Oka, Shintaro ^a   Matsuyama, Hideyasu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADOLESCENT; ADULT; ARTICLE; AZOOSPERMIA; CLINICAL ARTICLE; EMOTION; FOLLITROPIN BLOOD LEVEL; HEALTH; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; MALE; MENTAL HEALTH; OLIGOSPERMIA; PAIN; PRIORITY JOURNAL; PSYCHOLOGY; QUALITY OF LIFE; SHORT FORM 36; SOCIAL INTERACTION; SPERMATOZOON DENSITY; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME; CLINICAL TRIAL; HYPOGONADISM; PATHOLOGY; QUESTIONNAIRE; YOUNG ADULT;

ADOLESCENT; ADULT; GONADOTROPINS; HUMANS; HYPOGONADISM; MALE; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84904399857     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12435     Document Type: Article

References (25)

1. Liu, P.Y., Turner, L., Rushford, D., et al,. (1999) Efficacy and safety of recombinant human follicle stimulating hormone (GONAL-f®) with urinary human chorionic gonadotropin for inductionof spermatogenesis and fertility in gonadotropin-deficient men. Human Reproduction, 14, 1540-1545.
2. Bouloux, P., Warne, D.W., &, Loumaye, E., (2002) Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertility & Sterility, 77, 270-273.
3. Okada, H., O'Dea, L., Decosterd, G., et al,. (2006) Combination therapy with recombinant human follicle-stimulating hormone (follitropin alfa; Gonalef®) and human chorionic gonadotropin is effective and well tolerated in azoospermic Japanese men with hypogonadotropin hypogonadism. Clinical Endocrinology Japonica, 54, 87-94.
4. Matsumoto, A.M., Snyder, P.J., Bhasin, S., et al,. (2009) Stimulation of spermtogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f®): long-term treatment in azoospermic men with hypogonadotropic hypogonadism. Fertility & Sterility, 92, 979-990.
5. Han, T.S., &, Bouloux, M.G., (2010) What is the optimal therapy for young males with hypogonadotropic hypogondadism? Clinical Endocrinology, 72, 731-737.
6. Susman, E.J., Inoff-Germain, G.E., Nottelmann, E.D., et al,. (1987) Hormones, emotional dispositions and aggressive attributes in young adolescents. Child Development, 58, 1114-1134.
7. Bhasin, S., Cunningham, G.R., Hayes, F.J., et al,. (2010) Task Force, Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 95, 2536-2559.
8. Ware, J.E., &, Sherbourne, C.D., (1992) The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473-483.
9. Fukuhara, S., Bito, S., Green, J., et al,. (1998) Translation, adaptation, and validation of the SF-36 health survey for use in Japan. Journal of Clinical Epidemiology, 51, 1037-1044.
10. Aydogan, U., Aydogdu, A., Akbulut, H., et al,. (2012) Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocrine Journal, 59, 1099-1105.
11. de Ronde, W., de Haan, A., &, Drent, M., (2009) Quality of life is reduced in patients with Klinefelter syndrome on androgen replacement therapy. European Journal of Endocrinology, 160, 465-468.
12. Fossa, S.D., Dahl, A., &, Loge, J.H., (2003) Fatigue, anxiety, and depression in long-term survivors of testicular cancer. Journal of Clinocal Oncology, 21, 1249-1254.
13. Fahmy, I., Kamal, A., Shamloul, R., et al,. (2004) ICSI using testicular sperm in male hypogonadotrophic hypogonadism unresponsive to gonadotrophin therapy. Human Reproduction, 19, 1558-1561.
14. Amano, T., Imao, T., Takemae, K., et al,. (2008) Profile of serum testosterone levels after application of testosterone ointment (Glowmin) and its clinical efficacy in late-onset hypogonadism patients. Journal of Sexual Medicine, 5, 1727-1736.
15. Tsujimura, A., Takada, S., Matsuoka, Y., et al,. (2008) Is discontinuation ofhormone replacement therapy possible for patients with late-onset hypogonadism? International Journal of Urology, 15, 625-629.
16. English, K.M., Steeds, R.P., Jones, T.H., et al,. (2000) Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double blind, placebo-controlled study. Circulation, 102, 1906-1911.
17. Ly, L.P., Jimenez, M., Zhuang, T.N., et al,. (2001) A doubleblind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosteron gel on muscular strength, mobility, and quality of life in older men partial androgen deficiency. Journal of Clinical Endocrinology & Metabolism, 86, 4078-4088.
18. Veras, A.B., &, Nardi, A.E., (2010) The complex relationship between hypogonadism and major depression in a young male. Progress in Neuro-Psycopharmacology & Biological Psychiatry, 34, 421-422.
19. Susman, E.J., Finkelstein, J.W., Chinchilli, V.M., et al,. (1998) The effect of sex hormone replacement therapy on behavior problems and moods in adolescents with delayed puberty. Journal of Pediatrics, 133, 521-525.
20. Domar, A.D., Broome, A., Zuttermeister, P.C., et al,. (1992) The prevalence and predictability of depression in infertile women. Fertility & Sterility, 58, 1158-1163.
21. Dwyer, A.A., Sykiotis, G.P., Hayes, F.J., et al,. 2013 Trial of Recombinant Follicle Stimulating Hormone (rFSH) Pre-treatment for GnRH-induced Fertility in Patients with Congenital Hypogonadotropic Hypogonadism. Journal of Clinical Endocrinology & Metabolism, 98, 1790-1795.
22. Raivio, T., Wikström, A.M., &, Dunkel, L., (2007) Treatment of gonadotrophins-deficient boys with recombinant human FSH, long-term observation and outcome. European Journal of Endocrinology, 156, 105-111.
23. Miyagawa, Y., Tsujimura, A., Matsumiya, K., et al,. (2005) Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: 30-year retrospective study. Journal of Urology, 173, 2072-2075.
24. Zacharin, M., Sabin, M.A., Nair, V.V., et al,. (2012) Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertility & Sterility, 98, 836-842.
25. Yasuda, M., Ide, H., Furuya, K., et al,. (2008) Salivary 8-OHdG: a useful biomarker for predicting severe ED and hypogonadism. Journal of Sexual Medicine, 5, 1482-1491.